Baqsimi 3 mg (Glucagon POWDER) 3 MG

BAQSIMI 3 MG is a nasal powder formulation of glucagon used for emergency treatment of severe hypoglycemia. This rapid-acting medication is designed for quick administration when oral glucose is not feasible.

Strength

3 MG

Manufacturer / TM Owner

AMPHASTAR PHARMACEUTICALS, INC.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

BAQSIMI 3 MG is primarily used for the treatment of severe hypoglycemia in diabetic patients who are unconscious or unable to swallow. It works by raising blood sugar levels quickly, providing a critical response in emergency situations. This medication is intended for use when other forms of glucose administration are not possible.

Side Effects

BAQSIMI 3 MG is designed to rapidly increase blood sugar levels. Common effects may include temporary nausea or vomiting due to its action on the digestive system. The medication is formulated to act quickly, providing immediate relief in emergency hypoglycemic events.

Precautions & Warnings

BAQSIMI 3 MG should be used strictly as directed by a healthcare professional. It is important to store the medication properly and ensure it is within its expiration date. Always keep it accessible in case of emergencies, and follow the instructions for administration carefully.

Avoid Interactions

BAQSIMI 3 MG may interact with other medications, particularly those affecting blood sugar levels. It is important to inform your healthcare provider about all medications you are taking. Avoid using BAQSIMI 3 MG with other glucagon products to prevent potential overdosing.

Frequently Asked Questions

BAQSIMI 3 MG is used for the emergency treatment of severe hypoglycemia in diabetic patients who are unconscious or unable to swallow.

BAQSIMI 3 MG works by rapidly increasing blood sugar levels, providing immediate relief in emergency hypoglycemic events.

BAQSIMI 3 MG may interact with other medications, so it is important to consult a healthcare provider before use.

Common effects may include temporary nausea or vomiting due to its action on the digestive system.

BAQSIMI 3 MG should be stored properly and kept accessible in case of emergencies, following the instructions provided.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.